The global transradial access devices market size was valued at USD 2.96 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 6.06 billion by 2034 at a CAGR of 8.3% during the forecast period 2026-2034. North America dominated the transradial access devices market with a market share of 38.5% in 2025.
Transradial access devices are medical devices used to gain access to the arterial system through the radial artery in the wrist during diagnostic and interventional cardiovascular procedures. They help improve procedural safety, reduce bleeding complications, and support faster patient recovery compared with traditional femoral artery access.
Download a Free Sample To learn more about this report,
Growing Preference for Radial Access in Minimally Invasive Cardiovascular Procedures
The global transradial access devices market is witnessing strong growth as healthcare providers increasingly prefer radial artery access over femoral access for coronary angiography and percutaneous coronary intervention (PCI). Transradial procedures are associated with lower bleeding complications, faster patient recovery, earlier hospital discharge, and improved patient comfort, making them the preferred approach in many cardiac catheterization laboratories. Continuous advancements in guidewires, sheaths, catheters, and hemostatic devices are further improving procedural success and encouraging wider clinical adoption. Growing cardiovascular disease prevalence and increasing volumes of minimally invasive cardiac interventions continue to strengthen the demand for transradial access devices worldwide.
For instance, in November 2024, the American Heart Association (AHA) updated its scientific guidance supporting the broader adoption of transradial access for coronary interventions due to its proven safety benefits and reduced vascular complications, reinforcing the continued growth of the global transradial access devices market.
Increasing Innovation in Vascular Access Devices and Hemostasis Technologies
Technological innovation is becoming a major trend in the global transradial access devices market, with manufacturers focusing on developing hydrophilic sheaths, low-profile catheters, advanced guidewires, and radial compression devices that improve procedural efficiency and patient outcomes. These innovations help reduce radial artery occlusion, improve physician control, and enhance post-procedure hemostasis. Healthcare providers are also adopting next-generation access devices to support same-day discharge protocols and improve workflow efficiency in catheterization laboratories.
For example, in 2025, leading medical device manufacturers continued to introduce advanced radial access platforms and hemostasis technologies designed to improve procedural safety and support the increasing global adoption of minimally invasive cardiovascular interventions. These product innovations are expected to accelerate the long-term growth of the transradial access devices market.
The transradial access devices market is driven by the increasing adoption of minimally invasive cardiovascular procedures, rising prevalence of coronary artery disease, growing preference for radial artery access over femoral access, continuous advancements in vascular access technologies, and improving healthcare infrastructure worldwide. These factors are encouraging healthcare providers to adopt transradial access devices to reduce bleeding complications, improve procedural outcomes, shorten hospital stays, and enhance patient recovery following cardiovascular interventions.
The transradial access devices market faces challenges from the high cost of advanced vascular access devices, limited availability of skilled interventional cardiologists, the steep learning curve associated with transradial procedures, the risk of radial artery occlusion, and inadequate healthcare infrastructure in developing countries. These factors can reduce the adoption of transradial procedures, increase procedural complexity, and limit market expansion, particularly in resource-constrained healthcare settings.
Expanding Adoption of Outpatient and Same-Day Cardiac Procedures
The expansion of outpatient cardiovascular care presents significant opportunities for the transradial access devices market. Hospitals and cardiac centres are increasingly adopting transradial procedures because they enable faster patient recovery, reduced bleeding complications, and shorter hospital stays compared with femoral access. Continuous advancements in hydrophilic sheaths, guidewires, catheters, and radial compression devices are improving procedural safety and efficiency. Furthermore, increasing investments in catheterization laboratories, expanding healthcare infrastructure, and the growing adoption of minimally invasive cardiovascular interventions across emerging economies are expected to create new growth opportunities for manufacturers and healthcare providers.
Limited Availability of Skilled Professionals and Procedural Complexity
One of the major challenges facing the global market is the limited availability of healthcare professionals with expertise in transradial intervention techniques. Many hospitals require additional training to improve procedural success rates, particularly for complex cardiovascular interventions. Additionally, anatomical variations of the radial artery, the need for specialized equipment, and the risk of procedural failure can increase procedure time and operational costs. Differences in healthcare infrastructure and unequal access to advanced cardiovascular care across developing regions further make it challenging for healthcare providers to achieve widespread adoption of modern transradial access devices while maintaining consistent clinical outcomes.
Request Customizationto receive a tailored report.
The catheters segment accounted for the largest share of the global transradial access devices market, holding 31.4% in 2025. The segment dominates due to the widespread use of catheters in coronary angiography and percutaneous coronary intervention (PCI) procedures. Increasing demand for minimally invasive cardiovascular interventions, along with advancements in catheter design that improve flexibility, navigation, and procedural efficiency, continues to support the segment's leading position.
The diagnostics & testing segment is expected to witness the fastest growth, registering a CAGR of 8.5% during the forecast period (2026–2034). The growth is driven by the rising number of diagnostic angiography procedures, increasing prevalence of cardiovascular diseases, and growing preference for transradial access due to its lower complication rates and faster patient recovery. Continuous improvements in diagnostic imaging technologies are further supporting segment growth.
The hospitals segment accounted for the largest share of the global transradial access devices market, holding 58.6% in 2025. The segment's dominance is attributed to the high volume of cardiovascular procedures performed in hospitals, the availability of advanced catheterization laboratories, and the presence of skilled interventional cardiologists. Increasing investments in healthcare infrastructure and the growing adoption of minimally invasive cardiac procedures continue to strengthen the demand for transradial access devices in hospital settings.
Speak to an Analystto discuss market opportunities.
North America dominated the global transradial access devices market, accounting for 38.5% of the market in 2025, valued at USD 1.14 billion, and is projected to grow at a CAGR of 7.4% during the forecast period. The region's leadership is driven by the high prevalence of cardiovascular diseases, widespread adoption of minimally invasive procedures, advanced catheterization laboratories, and favourable reimbursement policies. Continuous technological innovations and the strong presence of leading medical device manufacturers further support regional market growth.
The U.S. transradial access devices market was valued at USD 0.92 billion in 2025. The country dominates the regional market due to the increasing volume of coronary angiography and percutaneous coronary intervention (PCI) procedures, advanced healthcare infrastructure, and growing preference for transradial access to reduce complications and improve patient outcomes.
The Canada transradial access devices market was valued at USD 0.22 billion in 2025. Growth is supported by increasing adoption of minimally invasive cardiovascular procedures, expanding access to advanced cardiac care, and rising investments in modern healthcare infrastructure. Growing awareness of the clinical benefits of transradial interventions is further driving market demand.
Europe accounted for 28.2% of the global transradial access devices market in 2025, reaching USD 0.83 billion, and is expected to grow at a CAGR of 8.6% during the forecast period. The region's growth is driven by increasing cardiovascular disease prevalence, favourable clinical guidelines supporting radial access, expanding adoption of minimally invasive interventions, and strong investments in healthcare innovation.
The UK transradial access devices market was valued at USD 0.25 billion in 2025. Rising demand for minimally invasive cardiovascular procedures, well-established cardiac care centres, and increasing adoption of advanced vascular access technologies continue to support market growth.
The Germany transradial access devices market was valued at USD 0.35 billion in 2025. Growth is driven by advanced healthcare infrastructure, increasing use of transradial interventions, and the presence of leading cardiovascular treatment centres. Continuous investment in innovative medical technologies further strengthens the market.
Asia Pacific held 22.7% of the global transradial access devices market in 2025, valued at USD 0.67 billion, and is projected to grow at a CAGR of 8.3% during the forecast period. The region is experiencing strong growth due to improving healthcare infrastructure, increasing cardiovascular disease burden, rising healthcare expenditure, and expanding access to minimally invasive cardiac procedures across developing economies.
The Japan transradial access devices market was valued at USD 0.21 billion in 2025. The country's advanced healthcare system, high adoption of minimally invasive cardiovascular procedures, and growing elderly population continue to drive demand for transradial access devices.
The China transradial access devices market was valued at USD 0.31 billion in 2025. Rapid expansion of healthcare infrastructure, increasing investments in cardiovascular care, rising incidence of heart disease, and growing adoption of advanced interventional cardiology procedures are supporting market growth.
The Middle East & Africa accounted for 4.5% of the global transradial access devices market in 2025, with a market value of USD 0.13 billion, and is projected to grow at a CAGR of 6.8% during the forecast period. Increasing investments in healthcare infrastructure, improving access to cardiovascular care, and growing awareness of minimally invasive procedures are contributing to market expansion across the region.
The UAE transradial access devices market was valued at USD 0.05 billion in 2025. Market growth is supported by increasing investments in advanced cardiac care facilities, rapid adoption of innovative medical technologies, and government initiatives to strengthen healthcare infrastructure.
The Africa transradial access devices market was valued at USD 0.08 billion in 2025. Growth is driven by improving access to cardiovascular healthcare, rising investments in hospital infrastructure, increasing awareness of minimally invasive interventions, and expanding healthcare services across several African countries.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com